Literature DB >> 7378249

Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue.

K E McColl, M R Moore, G G Thompson, A Goldberg.   

Abstract

1 In rats daily phenytoin (DPH) administration resulted in an increase in hepatic cytochrome P450 content. The rise in cytochrome P450 was associated with a temporary increase in the acitvity of hepatic delta-aminolaevulinic acid (ALA) synthase. 2 In patients newly commenced on DPH anticonvulsant therapy the activity of ALA synthase in peripheral leucocytes showed a marked temporary increase during the first 10 days of therapy. 3 These findings suggest that DPH induces a haem-requiring eenzyme system in peripheral leucocytes as well as in hepatic tissue.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378249      PMCID: PMC1429979          DOI: 10.1111/j.1365-2125.1980.tb01058.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  On the sequence of reactions leading to cytochrome P-450 synthesis-effect of drugs.

Authors:  C Rajamanickam; M R Rao; G Padmanaban
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

2.  Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood.

Authors:  M J Brodie; G G Thompson; M R Moore; A D Beattie; A Goldberg
Journal:  Q J Med       Date:  1977-04

3.  Role of haem in the synthesis and assembly of cytochrome P-450.

Authors:  K S Bhat; M K Sardana; G Padmanaban
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

4.  Drug sensitivity in hereditary hepatic porphyria.

Authors:  U A Meyer
Journal:  Hum Genet Suppl       Date:  1978

5.  Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase.

Authors:  R K Parikh; M R Moore
Journal:  Br J Anaesth       Date:  1978-11       Impact factor: 9.166

6.  Drug stimulation of -aminolevulinic acid synthetase and cytochrome P-450 in vivo in chick embryo liver.

Authors:  A B Rifkind; P N Gillette; C S Song; A Kappas
Journal:  J Pharmacol Exp Ther       Date:  1973-05       Impact factor: 4.030

7.  Trimethoprim-induced elevation of dihydrofolate reductase activity in human leukocytes.

Authors:  M F Martelli; F Aversa; P Rambotti; A Velardi
Journal:  Enzyme       Date:  1978

8.  Human hepatic delta-aminolaevulinate synthase: requirement of an exogenous system for succinyl-coenzyme A generation to demonstrate increased activity in cirrhotic and anticonvulsant-treated subjects.

Authors:  H L Bonkowsky; J S Pomeroy
Journal:  Clin Sci Mol Med       Date:  1977-05

9.  A model for the regulation of delta-aminolaevulinate synthetase induction in rat liver.

Authors:  G Padmanaban; M R Rao; K Malathi
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

10.  Stimulation of liver 5-aminolaevulinate synthetase by drugs and its relevance to drug-induced accumulation of cytochrome P-450. Studies with phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.

Authors:  F De Matteis; A Gibbs
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

View more
  8 in total

1.  Studies in laboratory animals to assess the safety of anti-inflammatory agents in acute porphyria.

Authors:  K E McColl; G G Thompson; M R Moore
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

2.  Effect of rifampicin on haem and bilirubin metabolism in man.

Authors:  K E McColl; G G Thompson; E el Omar; M R Moore; B K Park; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

3.  Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.

Authors:  K E McColl; M R Moore; G G Thompson; A Goldberg
Journal:  J Med Genet       Date:  1982-08       Impact factor: 6.318

4.  Effect of stanozolol on delta-aminolaevulinic acid synthase and hepatic monooxygenase activity in man and rat.

Authors:  G G Thompson; M Small; G D Lowe; C D Forbes; B K Park; G Scobie; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine.

Authors:  W G Rapeport; G T McInnes; G G Thompson; G Forrest; B K Park; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

6.  The effects of chronic carbamazepine treatment of haem biosynthesis in man and rat.

Authors:  G M McGuire; G J Macphee; G G Thompson; B K Park; M R Moore; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.

Authors:  A L Herrick; K E McColl; M R Moore; M J Brodie; A R Adamson; A Goldberg
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

8.  Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.

Authors:  W B Mattes; H G Kamp; E Fabian; M Herold; G Krennrich; R Looser; W Mellert; A Prokoudine; V Strauss; B van Ravenzwaay; T Walk; H Naraoka; K Omura; I Schuppe-Koistinen; S Nadanaciva; E D Bush; N Moeller; P Ruiz-Noppinger; S P Piccoli
Journal:  Biomed Res Int       Date:  2013-05-21       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.